Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

FRAX updates 2012.

McCloskey E, Kanis JA.

Curr Opin Rheumatol. 2012 Sep;24(5):554-60. doi: 10.1097/BOR.0b013e328356d2f5. Review.

PMID:
22820516
[PubMed - indexed for MEDLINE]
2.

Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.

Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A; National Osteoporosis Guideline Group.

Osteoporos Int. 2008 Oct;19(10):1395-408. doi: 10.1007/s00198-008-0712-1. Epub 2008 Aug 28. Erratum in: Osteoporos Int. 2009 Mar;20(3):499-502.

PMID:
18751937
[PubMed - indexed for MEDLINE]
3.

The Fracture Risk Assessment Tool (FRAX®): applications in clinical practice.

Watts NB.

J Womens Health (Larchmt). 2011 Apr;20(4):525-31. doi: 10.1089/jwh.2010.2294. Epub 2011 Mar 25.

PMID:
21438699
[PubMed - indexed for MEDLINE]
4.

Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.

Siris ES, Baim S, Nattiv A.

Postgrad Med. 2010 Jan;122(1):82-90. doi: 10.3810/pgm.2010.01.2102. Review.

PMID:
20107292
[PubMed - indexed for MEDLINE]
5.

[Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].

Lippuner K.

Ther Umsch. 2012 Mar;69(3):207-13. doi: 10.1024/0040-5930/a000275. German.

PMID:
22403115
[PubMed - indexed for MEDLINE]
6.

Fracture risk assessment.

McCloskey E, Johansson H, Oden A, Kanis JA.

Clin Biochem. 2012 Aug;45(12):887-93. doi: 10.1016/j.clinbiochem.2012.05.001. Epub 2012 May 8. Review.

PMID:
22579965
[PubMed - indexed for MEDLINE]
7.

[Efficacy of densitometry and fracture risk assessment tool FRAX in making therapeutic decisions in osteoporosis--a study on female patients of university of medical sciences endocrinology outpatient clinic].

Ignaszak-Szczepaniak M, Dytfeld J, Michalak M, Gowin E, Horst-Sikorska W.

Ginekol Pol. 2009 Jun;80(6):424-31. Polish.

PMID:
19642598
[PubMed - indexed for MEDLINE]
8.

Assessment of individual fracture risk: FRAX and beyond.

van den Bergh JP, van Geel TA, Lems WF, Geusens PP.

Curr Osteoporos Rep. 2010 Sep;8(3):131-7. doi: 10.1007/s11914-010-0022-3.

PMID:
20563901
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Guidance for the adjustment of FRAX according to the dose of glucocorticoids.

Kanis JA, Johansson H, Oden A, McCloskey EV.

Osteoporos Int. 2011 Mar;22(3):809-16. doi: 10.1007/s00198-010-1524-7. Epub 2011 Jan 13.

PMID:
21229233
[PubMed - indexed for MEDLINE]
10.

New guidelines for the prevention and treatment of osteoporosis.

Lewiecki EM, Watts NB.

South Med J. 2009 Feb;102(2):175-9. doi: 10.1097/SMJ.0b013e31818be99b. Review.

PMID:
19139693
[PubMed - indexed for MEDLINE]
11.

[Absolute risk for fracture and WHO guideline. Fracture risk assessments recommended by World Health Organization and Japanese guidelines for prevention and treatment of osteoporosis 2006].

Nakamura T; World Health Organization.

Clin Calcium. 2007 Jul;17(7):1022-8. Review. Japanese.

PMID:
17607068
[PubMed - indexed for MEDLINE]
12.

Interpretation and use of FRAX in clinical practice.

Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, El-Hajj Fuleihan G, Johansson H, Leslie WD, Lewiecki EM, Luckey M, Oden A, Papapoulos SE, Poiana C, Rizzoli R, Wahl DA, McCloskey EV; Task Force of the FRAX Initiative.

Osteoporos Int. 2011 Sep;22(9):2395-411. doi: 10.1007/s00198-011-1713-z. Epub 2011 Jul 21. Review.

PMID:
21779818
[PubMed - indexed for MEDLINE]
13.

Development and use of FRAX in osteoporosis.

Kanis JA, McCloskey EV, Johansson H, Oden A, Ström O, Borgström F.

Osteoporos Int. 2010 Jun;21 Suppl 2:S407-13. doi: 10.1007/s00198-010-1253-y. Epub 2010 May 13. Review.

PMID:
20464374
[PubMed - indexed for MEDLINE]
14.

Official Positions for FRAX(®) clinical regarding glucocorticoids: the impact of the use of glucocorticoids on the estimate by FRAX(®) of the 10 year risk of fracture from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®).

Leib ES, Saag KG, Adachi JD, Geusens PP, Binkley N, McCloskey EV, Hans DB; FRAX(®) Position Development Conference Members.

J Clin Densitom. 2011 Jul-Sep;14(3):212-9. doi: 10.1016/j.jocd.2011.05.014.

PMID:
21810527
[PubMed - indexed for MEDLINE]
15.

Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.

Fraser LA, Langsetmo L, Berger C, Ioannidis G, Goltzman D, Adachi JD, Papaioannou A, Josse R, Kovacs CS, Olszynski WP, Towheed T, Hanley DA, Kaiser SM, Prior J, Jamal S, Kreiger N, Brown JP, Johansson H, Oden A, McCloskey E, Kanis JA, Leslie WD; CaMos Research Group.

Osteoporos Int. 2011 Mar;22(3):829-37. doi: 10.1007/s00198-010-1465-1. Epub 2010 Dec 16.

PMID:
21161508
[PubMed - indexed for MEDLINE]
16.

Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.

Leslie WD, Lix LM, Langsetmo L, Berger C, Goltzman D, Hanley DA, Adachi JD, Johansson H, Oden A, McCloskey E, Kanis JA.

Osteoporos Int. 2011 Mar;22(3):817-27. doi: 10.1007/s00198-010-1464-2. Epub 2010 Dec 16.

PMID:
21161509
[PubMed - indexed for MEDLINE]
17.

Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.

Levis S, Theodore G.

J Manag Care Pharm. 2012 May;18(4 Suppl B):S1-15; discussion S13.

PMID:
22716221
[PubMed - indexed for MEDLINE]
Free Article
18.

FRAX and its applications in health economics--cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example.

Ström O, Borgström F, Kleman M, McCloskey E, Odén A, Johansson H, Kanis JA.

Bone. 2010 Aug;47(2):430-7. doi: 10.1016/j.bone.2010.05.020. Epub 2010 May 20.

PMID:
20493983
[PubMed - indexed for MEDLINE]
19.

Critical points in strategies for the diagnosis and treatment of osteoporosis.

Lorenc RS, Misiorowski W, Karczmarewicz E.

Endokrynol Pol. 2009 Mar-Apr;60(2):124-33. Review.

PMID:
19396756
[PubMed - indexed for MEDLINE]
20.

The distribution of FRAX(®)-based probabilities in women from Japan.

Kanis JA, Johansson H, Odén A, McCloskey EV.

J Bone Miner Metab. 2012 Nov;30(6):700-5. doi: 10.1007/s00774-012-0371-3. Epub 2012 Aug 22.

PMID:
22911378
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk